Baker Bros. Advisors LP Bicycle Therapeutics PLC Transaction History
Baker Bros. Advisors LP
- $8.39 Billion
- Q1 2025
A detailed history of Baker Bros. Advisors LP transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Baker Bros. Advisors LP holds 10,885,357 shares of BCYC stock, worth $85.6 Million. This represents 1.1% of its overall portfolio holdings.
Number of Shares
10,885,357
Previous 10,885,357
-0.0%
Holding current value
$85.6 Million
Previous $152 Million
39.36%
% of portfolio
1.1%
Previous 1.69%
Shares
5 transactions
Others Institutions Holding BCYC
# of Institutions
100Shares Held
43.2MCall Options Held
15.6KPut Options Held
27.7K-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.69MShares$29 Million0.08% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.45MShares$27.1 Million7.08% of portfolio
-
Armistice Capital, LLC New York, NY2.67MShares$21 Million0.35% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.66MShares$20.9 Million0.12% of portfolio
-
Siren, L.L.C. New York, NY1.81MShares$14.2 Million0.88% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $233M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...